What pharmacists can do to help our mental health crisis
Pharmacists responded to a significant increase in prescription demand when there were disrupted supply chains, keeping essential medication supplies and management services, keeping communities connected and delivering vaccination services when it mattered most.
This period offers profound insights into the capability of community pharmacists to pivot and support a public health system in crisis. As New Zealand confronts a deepening post-pandemic mental health crisis, a pressing question arises: can community pharmacists similarly help ensure there is prompt access to mental health support?
We argue that community pharmacists are well-positioned to do so. According to the latest figures from the Pharmaceutical Society New Zealand, there are more than 1200 community pharmacies seeing about 1.3 million people each month in total. The very notion of community is embedded in the professional identity of community pharmacists; they are deeply integrated into the neighbourhoods and regions they serve.
Unlike many healthcare professionals who are concentrated in urban hospitals or clinics, community pharmacists are accessible far beyond the main centres, including rural and remote areas.
Pharmacists are often the most public-facing touchpoint in the healthcare system, providing a familiar and approachable setting. Pharmacists are funded to offer a range of physical health services for conditions such as diabetes, heart disease, hypertension, asthma, rheumatoid arthritis and chronic pain. They routinely inform and guide patients on medication use, adjust regimens, and monitor medication adherence.
Pharmacists are also able to provide 'whole-of-life vaccinations' from children to older adults and, increasingly, to supply prescription-only medication without a prescription to support better access, such as for Covid-19 antivirals and Hepatitis C medication. If pharmacists are already trusted with the management of these complex, physical health conditions, why not include mental health as a priority funded service?
Extending pharmacy services to mental health support would be a logical progression of the work community pharmacists already do. Their regular customers are often managing chronic health conditions that can be intertwined with mental health challenges. Physical illnesses such as diabetes, heart or respiratory disease often coexist with depression, anxiety, or insomnia, and treatment can be complicated by the interplay of physical and mental health symptoms. Pharmacists are therefore already well-positioned to help bridge the gap in current mental health service provision.
Pharmacists receive rigorous training in the safe and effective use of medicines. Their education covers not only the pharmacological properties and interactions of drugs but also the broader principles of medication management, adherence, and patient counselling.
This includes a focus on psychiatric medications – for example antidepressants, antipsychotics, mood stabilisers, and anxiolytics. Their ability to recognise and discuss potential side effects, monitor adherence, and identify risks, such as the dangers of abruptly stopping medication, is well-known.
In practice, this expertise could translate into a range of supportive actions for people with mental health needs: pharmacists could initiate conversations about medication experiences, help manage side-effects, encourage ongoing adherence, and act as a first point of contact for mental health concerns or questions, thereby helping to prevent complications or relapses.
Community pharmacists could also alert other clinicians such as general practitioners or specialist mental health services when more support may be needed. Pharmacists could also train to become pharmacist prescribers to support ongoing prescription of mental health medication in collaboration with a healthcare team.
Indeed, pharmacists are increasingly being recognised as key community health professionals, and their role is expanding rapidly. Recent initiatives, such as the Expanded Pharmacist Prescribing Programme, aim to boost access to care, especially in rural and underserved communities, but they also position pharmacists as frontline providers of medicines management, patient education, and collaborative care. This evolution is part of a broader effort to modernise and diversify the health workforce, reduce pressure on GPs, and improve patient access to prompt care. This move thus reinforces the potential of community pharmacists to provide physical and mental health care.
Research we and others have conducted in New Zealand with community pharmacists reveals enthusiasm about expanding their mental health role and interaction with customers. Many pharmacists see it as an opportunity to offer more mental health support as a natural extension of their commitment to holistic patient care.
Pharmacists recognise the trust placed in them by the public and are motivated to provide more comprehensive support in collaboration with other clinicians and disciplines. In New Zealand, community pharmacists have been found to have good mental health literacy in identifying conditions such as depression and have positive attitudes towards those with mental illness and are willing to provide mental health support.
If community pharmacists were involved in mental health care, it would lead to the early identification of mental health symptoms and improved continuity of care. It would also be professionally rewarding for pharmacists, enabling them to work to the top of their scope of practice.
However, pharmacists have also expressed concerns: the need for additional training, clear protocols, shared digital/electronic health record platforms, safeguards to manage the complexity of mental health needs and funded pathways to provide such services. Additionally, there are legitimate concerns about time and space constraints, the boundaries of their professional role, and the availability of referral pathways for patients requiring more intensive support. These perspectives underscore the importance of careful planning and resourcing for any expansion of pharmacist-led mental health services.
But this is achievable, and there are existing models of pharmacist-delivered mental health services, such as the Bloom programme in Canada. There are also social prescribing initiatives in the United Kingdom that involve community pharmacists together with other disciplines to provide support with health system navigation, harm reduction and person-centred care. In Australia, there are active trials evaluating the role of community pharmacies to provide physical and mental health support. In New Zealand, we will need more research and policy development to inform and guide effective models of care.
We hope to collaborate closely with the community pharmacy sector to co-design a practical programme to suit various settings and communities, with careful evaluation of outcomes for patients and pharmacists. Such a programme would aim to build on existing strengths so that mental health support is accessible at the grassroots level.
Community pharmacists are highly skilled and accessible healthcare professionals whose skills could be better deployed within the healthcare system.
Many are drawn to the profession to serve and engage with their communities. By equipping them with the right resources and training, there is real potential to help address both the mental health crisis and the pressures on our overloaded healthcare system, and where pharmacies can truly function as a key healthcare hub in the community.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
9 hours ago
- Otago Daily Times
Social worker suspended over dodgy Covid vaccine exemption
A Dunedin-based social worker who issued a shonky Covid-19 vaccine exemption has been suspended for a year. Dr Jacquelyn Elkington's case came before the Social Workers Complaints and Disciplinary Tribunal yesterday — but she did not. Elderly pay price for Covid 'complacency' The woman, who is listed on the University of Otago's website as a senior lecturer hauora Māori, failed to show up for the hearing and was promptly found guilty of professional misconduct after tribunal chairman Winston McCarthy found her behaviour was likely to bring discredit to the profession. It was the first time a social worker has been taken to task over a Covid-19 issue and co-counsel for the professional conduct committee (PCC) Becca Boles said the only appropriate penalty was deregistration. But the tribunal opted to suspend Dr Elkington for 12 months, censuring her and ordering her to pay costs of more than $13,000. In November 2021, during the height of the Covid-19 pandemic, the government introduced legislation narrowing the grounds for a vaccine exemption. Only a suitably qualified health practitioner could make the assessment and it had to be verified by the country's director-general of health. A month later, Dr Elkington — who was working in Auckland at the time — issued such an exemption for a "vulnerable" client. "She's not a medical practitioner, she's a social worker," PCC co-counsel Elena Mok said. "Her conduct took her outside the scope of her practice." A day later, the man used the exemption in a bid to gain entry to a recreational facility. A staff member subsequently raised suspicions and referred the matter to the health and disability commissioner (HDC). Ms Mok said Dr Elkington's conduct "snowballed" from that point, Dr Elkington thwarting the resulting investigations against her by repeatedly failing to provide information. In June 2022, the woman made an online application to renew her practising certificate with the Social Workers Registration Board. Dr Elkington falsely indicated she was not subject to any inquiry and when she was pulled up on her lie, she claimed she thought the HDC inquiry had closed. But a couple of months later she resubmitted the online application, again declaring she was free of any scrutiny. Dr Elkington's behaviour was "at least misleading, if not outright false", Ms Mok said. The social worker went on to claim she felt "harassed and threatened" by the probe into her conduct, and that it was "borderline bullying". Many requests for information — about client notes or records on how many vaccine exemptions she had issued — throughout 2024, after the file was passed on to the PCC, were met with silence. At other points, Dr Elkington said she could not provide the documentation as she did not have the consent of her clients. She occasionally claimed to have already submitted the requested information and also made references to the Bill of Rights Act and various international treaties. On one occasion Dr Elkington referred to the River of Lies documentary — which bills itself as revealing the truth behind the "New Zealand scamdemic" — produced by the controversial Billy Te Kahika. Her lack of engagement in the process showed a disrespect for the process and an ongoing lack of remorse and insight, reinforced by her non-attendance at yesterday's hearing, the PCC argued. "The vaccine exemption appears to have been issued because of Dr Elkington's personal beliefs about the safety of the vaccine and her views on the Covid pandemic," Ms Mok said. "Dr Elkington's attempt to justify her approach is an example of her effectively allowing these personal beliefs to influence her social work practice unduly." The University of Otago refused to answer questions about the woman's employment at the institution. In 2022, Dr Elkington ran for the Whakatāne mayoralty and posted online at the time her various theories, which included that the Covid-19 vaccination caused monkeypox. She came sixth out of seven candidates. Dr Elkington did not respond to requests for comment. The tribunal ordered that if the social worker returned to practice she must undertake monthly supervision for a year.
Newsroom
3 days ago
- Newsroom
What pharmacists can do to help our mental health crisis
Opinion: The Covid-19 pandemic highlighted weaknesses and strengths in New Zealand's healthcare system. Community pharmacists emerged as one of its quiet powerhouses. When Level 4 restrictions hit in 2020 and many routine health services became inaccessible almost overnight, pharmacies stayed opened, adapting quickly and serving as a critical frontline for many communities. Pharmacists responded to a significant increase in prescription demand when there were disrupted supply chains, keeping essential medication supplies and management services, keeping communities connected and delivering vaccination services when it mattered most. This period offers profound insights into the capability of community pharmacists to pivot and support a public health system in crisis. As New Zealand confronts a deepening post-pandemic mental health crisis, a pressing question arises: can community pharmacists similarly help ensure there is prompt access to mental health support? We argue that community pharmacists are well-positioned to do so. According to the latest figures from the Pharmaceutical Society New Zealand, there are more than 1200 community pharmacies seeing about 1.3 million people each month in total. The very notion of community is embedded in the professional identity of community pharmacists; they are deeply integrated into the neighbourhoods and regions they serve. Unlike many healthcare professionals who are concentrated in urban hospitals or clinics, community pharmacists are accessible far beyond the main centres, including rural and remote areas. Pharmacists are often the most public-facing touchpoint in the healthcare system, providing a familiar and approachable setting. Pharmacists are funded to offer a range of physical health services for conditions such as diabetes, heart disease, hypertension, asthma, rheumatoid arthritis and chronic pain. They routinely inform and guide patients on medication use, adjust regimens, and monitor medication adherence. Pharmacists are also able to provide 'whole-of-life vaccinations' from children to older adults and, increasingly, to supply prescription-only medication without a prescription to support better access, such as for Covid-19 antivirals and Hepatitis C medication. If pharmacists are already trusted with the management of these complex, physical health conditions, why not include mental health as a priority funded service? Extending pharmacy services to mental health support would be a logical progression of the work community pharmacists already do. Their regular customers are often managing chronic health conditions that can be intertwined with mental health challenges. Physical illnesses such as diabetes, heart or respiratory disease often coexist with depression, anxiety, or insomnia, and treatment can be complicated by the interplay of physical and mental health symptoms. Pharmacists are therefore already well-positioned to help bridge the gap in current mental health service provision. Pharmacists receive rigorous training in the safe and effective use of medicines. Their education covers not only the pharmacological properties and interactions of drugs but also the broader principles of medication management, adherence, and patient counselling. This includes a focus on psychiatric medications – for example antidepressants, antipsychotics, mood stabilisers, and anxiolytics. Their ability to recognise and discuss potential side effects, monitor adherence, and identify risks, such as the dangers of abruptly stopping medication, is well-known. In practice, this expertise could translate into a range of supportive actions for people with mental health needs: pharmacists could initiate conversations about medication experiences, help manage side-effects, encourage ongoing adherence, and act as a first point of contact for mental health concerns or questions, thereby helping to prevent complications or relapses. Community pharmacists could also alert other clinicians such as general practitioners or specialist mental health services when more support may be needed. Pharmacists could also train to become pharmacist prescribers to support ongoing prescription of mental health medication in collaboration with a healthcare team. Indeed, pharmacists are increasingly being recognised as key community health professionals, and their role is expanding rapidly. Recent initiatives, such as the Expanded Pharmacist Prescribing Programme, aim to boost access to care, especially in rural and underserved communities, but they also position pharmacists as frontline providers of medicines management, patient education, and collaborative care. This evolution is part of a broader effort to modernise and diversify the health workforce, reduce pressure on GPs, and improve patient access to prompt care. This move thus reinforces the potential of community pharmacists to provide physical and mental health care. Research we and others have conducted in New Zealand with community pharmacists reveals enthusiasm about expanding their mental health role and interaction with customers. Many pharmacists see it as an opportunity to offer more mental health support as a natural extension of their commitment to holistic patient care. Pharmacists recognise the trust placed in them by the public and are motivated to provide more comprehensive support in collaboration with other clinicians and disciplines. In New Zealand, community pharmacists have been found to have good mental health literacy in identifying conditions such as depression and have positive attitudes towards those with mental illness and are willing to provide mental health support. If community pharmacists were involved in mental health care, it would lead to the early identification of mental health symptoms and improved continuity of care. It would also be professionally rewarding for pharmacists, enabling them to work to the top of their scope of practice. However, pharmacists have also expressed concerns: the need for additional training, clear protocols, shared digital/electronic health record platforms, safeguards to manage the complexity of mental health needs and funded pathways to provide such services. Additionally, there are legitimate concerns about time and space constraints, the boundaries of their professional role, and the availability of referral pathways for patients requiring more intensive support. These perspectives underscore the importance of careful planning and resourcing for any expansion of pharmacist-led mental health services. But this is achievable, and there are existing models of pharmacist-delivered mental health services, such as the Bloom programme in Canada. There are also social prescribing initiatives in the United Kingdom that involve community pharmacists together with other disciplines to provide support with health system navigation, harm reduction and person-centred care. In Australia, there are active trials evaluating the role of community pharmacies to provide physical and mental health support. In New Zealand, we will need more research and policy development to inform and guide effective models of care. We hope to collaborate closely with the community pharmacy sector to co-design a practical programme to suit various settings and communities, with careful evaluation of outcomes for patients and pharmacists. Such a programme would aim to build on existing strengths so that mental health support is accessible at the grassroots level. Community pharmacists are highly skilled and accessible healthcare professionals whose skills could be better deployed within the healthcare system. Many are drawn to the profession to serve and engage with their communities. By equipping them with the right resources and training, there is real potential to help address both the mental health crisis and the pressures on our overloaded healthcare system, and where pharmacies can truly function as a key healthcare hub in the community.
NZ Herald
4 days ago
- NZ Herald
‘Working really hard': Whanganui child immunisation rates rise amid disease outbreaks
'Rates have risen from around 70% in late 2024 to around 77%. Notably, coverage for Māori children has also risen in that time from below 60% to around 75%.' Whanganui Regional Health Network (WRHN) and Te Oranganui said the results were due to hard work despite difficult circumstances, including the cost of living, lasting effects from Covid-19, and childhood disease outbreaks. At the start of July, a measles outbreak was detected in the Wairarapa area. It spread to Feilding with eight reported cases. Whanganui was identified as a hotspot for the whooping cough epidemic in November 2024 with a rate of infection at 11.4 cases per 100,000 people. 'We are really concerned,' WRHN immunisation co-ordinator Sue Hina said. She said there was some reluctance to immunisation 'from Covid-19 from when the ministry put in the mandates so people think 'don't tell me what to do'.' Te Oranganui chief executive Wheturangi Walsh-Tapiata said it was 'heartening' to see a recent increase in immunisations. 'It's been a challenging space to get whānau to understand the importance in particular of their child immunisations since Covid times,' she said. Hina said there had been increased focus on educating families to be able to make an informed decision on whether to immunise their children. 'That's making sure there's enough access for people, enough information for people, enough follow-up to those that are hesitant,' Hina said. 'People have the right to decline but we want to get to the point where the people declining can have a conversation with us.' She said the cost of living crisis had also placed barriers for struggling families to get immunised. 'The social determinants make a big difference; if you haven't got a house to live in or you can't pay your rent or put food on the table, you're less likely to be worried about whether your immunisations get done or not,' Hina said. Walsh-Tapiata said it was important to talk to people in their communities. 'The critical point of difference in terms of our services is that we go to them.' It was not only Te Oranganui that worked in this way to improve healthcare provision, but iwi Māori hauora providers throughout the region. 'There has been a really collective approach by the Iwi Māori Hauora providers throughout the region to address child immunisations initially and then overall immunisations,' Walsh-Tapiata said. Meanwhile, O'Connor said more work was needed to reach the 95% national target by 2030 but the progress was promising. 'And it is down to the tireless, collective efforts of our community and primary care provider partners, supported by the Whanganui Regional Health Network.' Olivia Reid is a multimedia journalist based in Whanganui.
